Publikasi Scopus 2024 per tanggal 30 September 2024 (820 artikel)

Andres E.B.; Yo V.; Balasubramanian I.; Poco L.; Ozdemir S.; Manalo M.F.; Rahman R.; Putranto R.; Zu W.W.M.; Palat G.; Mariam L.; Tuong P.N.; Malhotra C.
Andres, Ellie Bostwick (26634860400); Yo, Valen (59212797700); Balasubramanian, Ishwarya (59177715400); Poco, Louisa (57210392354); Ozdemir, Semra (35553994400); Manalo, Maria Fidelis (55826067700); Rahman, Rubaiyat (57211407481); Putranto, Rudi (56074051000); Zu, Wah Wah Myint (57217486003); Palat, Gayatri (12800879800); Mariam, Lubna (57226118551); Tuong, Pham Nguyen (57218932132); Malhotra, Chetna (24338706400)
26634860400; 59212797700; 59177715400; 57210392354; 35553994400; 55826067700; 57211407481; 56074051000; 57217486003; 12800879800; 57226118551; 57218932132; 24338706400
Opioid Access among Advanced Cancer Patients in Low- and Middle-Income Countries in Asia
2024
Journal of Pain and Symptom Management
68
4
352
359
7
0
Lien Centre for Palliative Care (E.B.A., V.Y., I.B., L.P., S.O., C.M.), Duke-NUS Medical School, Singapore, Singapore, Singapore; Section of Supportive Oncology & Palliative Care, The Medical City (M.F.M.), Pasig, Philippines; Bangabandhu Sheikh Mujib Medical University (R.R.), Dhaka, Bangladesh; Rumah Sakit Umum Pusat Nasional (R.P.), Dr. Cipto Mangunkusumo, Jakarta, Indonesia; Division of Psychosomatic and Palliative Medicine (R.P.), Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Clinical Research Division (W.W.M.Z.), Yangon General Hospital, Yangon, Myanmar; Department of Palliative Medicine (G.P.), MNJ Institute of Oncology and Regional Cancer Centre Hyderabad, India; Department of Radiation Oncology, National Institute of Cancer Research and Hospital (L.M.), Dhaka, Bangladesh; Oncology Center (P.N.T.), Hue Central Hospital, Hue, Hue City, Viet Nam
Andres E.B., Lien Centre for Palliative Care (E.B.A., V.Y., I.B., L.P., S.O., C.M.), Duke-NUS Medical School, Singapore, Singapore, Singapore; Yo V., Lien Centre for Palliative Care (E.B.A., V.Y., I.B., L.P., S.O., C.M.), Duke-NUS Medical School, Singapore, Singapore, Singapore; Balasubramanian I., Lien Centre for Palliative Care (E.B.A., V.Y., I.B., L.P., S.O., C.M.), Duke-NUS Medical School, Singapore, Singapore, Singapore; Poco L., Lien Centre for Palliative Care (E.B.A., V.Y., I.B., L.P., S.O., C.M.), Duke-NUS Medical School, Singapore, Singapore, Singapore; Ozdemir S., Lien Centre for Palliative Care (E.B.A., V.Y., I.B., L.P., S.O., C.M.), Duke-NUS Medical School, Singapore, Singapore, Singapore; Manalo M.F., Section of Supportive Oncology & Palliative Care, The Medical City (M.F.M.), Pasig, Philippines; Rahman R., Bangabandhu Sheikh Mujib Medical University (R.R.), Dhaka, Bangladesh; Putranto R., Rumah Sakit Umum Pusat Nasional (R.P.), Dr. Cipto Mangunkusumo, Jakarta, Indonesia, Division of Psychosomatic and Palliative Medicine (R.P.), Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Zu W.W.M., Clinical Research Division (W.W.M.Z.), Yangon General Hospital, Yangon, Myanmar; Palat G., Department of Palliative Medicine (G.P.), MNJ Institute of Oncology and Regional Cancer Centre Hyderabad, India; Mariam L., Department of Radiation Oncology, National Institute of Cancer Research and Hospital (L.M.), Dhaka, Bangladesh; Tuong P.N., Oncology Center (P.N.T.), Hue Central Hospital, Hue, Hue City, Viet Nam; Malhotra C., Lien Centre for Palliative Care (E.B.A., V.Y., I.B., L.P., S.O., C.M.), Duke-NUS Medical School, Singapore, Singapore, Singapore
Context: Most cancer-associated pain is experienced in low- and middle-income countries (LMICs) due to inequitable access to opioids. Objective: To determine opioid access as estimated by both patients and providers and to understand patient and facility-level factors influencing access among patients with advanced cancer in LMICs in Asia using the Behavioral Model of Health Services Use. Methods: The APPROACH cross-sectional study was conducted in seven LMICs in Asia, involving in-depth surveys with providers and advanced cancer patients. A hierarchical logistic regression model was used to assess predisposing (i.e. individual factors), enabling (i.e. health care system and facility-level resources) and need (i.e. pain severity) factors predicting opioid access. Results: Among patient participants (n=1,933), approximately 40% reported opioid use. Meanwhile 80% of facilities, as reported by providers, indicated at least half of their advanced cancer patients receive oral morphine prescriptions. Predisposing characteristics factored in the least in the model, with patient education positively associated with access (Odds ratio (OR): 1.01; 95% CI=1.00, 1.03). Facility-level enabling resources, factoring the most, included oral morphine prescription duration >14 days (OR: 1.27; 95% CI=1.05, 1.53) and the extent of physician palliative care training (extensive (>160 hours) OR: 3.95; CI=3.19, 4.88; basic (up to 40 hours) OR: 1.03; CI=1.03, 1.04). Patient need as indicated by greater pain severity predicted access (OR: 1.55; CI=1.47, 1.64). Conclusion: Study findings emphasize the importance of palliative care training—even a minimal amount—in supporting access to opioids for advanced cancer patients. This study also highlights pragmatic site-level policies, such as extended morphine prescription durations, enabling access. © 2024 American Academy of Hospice and Palliative Medicine
access; behavioral model of health services use; cancer; LMICs; opioids; palliative care
Adult; Aged; Analgesics, Opioid; Asia; Cancer Pain; Cross-Sectional Studies; Developing Countries; Female; Health Services Accessibility; Humans; Male; Middle Aged; Neoplasms; morphine; opiate; narcotic analgesic agent; access to medication; advanced cancer; Article; Asia; cancer palliative therapy; cancer patient; cross-sectional study; female; human; low income country; major clinical study; male; medical education; middle income country; pain severity; patient education; physician; prescription; adult; aged; cancer pain; complication; developing country; drug therapy; health care access; middle aged; neoplasm
Elsevier Inc.
08853924
38964427
Article
Q1
1186
3353